全文获取类型
收费全文 | 1583篇 |
免费 | 97篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 57篇 |
妇产科学 | 110篇 |
基础医学 | 201篇 |
口腔科学 | 9篇 |
临床医学 | 102篇 |
内科学 | 246篇 |
皮肤病学 | 7篇 |
神经病学 | 469篇 |
特种医学 | 41篇 |
外科学 | 156篇 |
综合类 | 2篇 |
预防医学 | 72篇 |
眼科学 | 35篇 |
药学 | 82篇 |
肿瘤学 | 90篇 |
出版年
2023年 | 15篇 |
2022年 | 22篇 |
2021年 | 33篇 |
2020年 | 16篇 |
2019年 | 29篇 |
2018年 | 38篇 |
2017年 | 31篇 |
2016年 | 27篇 |
2015年 | 31篇 |
2014年 | 62篇 |
2013年 | 71篇 |
2012年 | 84篇 |
2011年 | 102篇 |
2010年 | 50篇 |
2009年 | 72篇 |
2008年 | 86篇 |
2007年 | 108篇 |
2006年 | 104篇 |
2005年 | 124篇 |
2004年 | 76篇 |
2003年 | 69篇 |
2002年 | 65篇 |
2001年 | 24篇 |
2000年 | 39篇 |
1999年 | 34篇 |
1998年 | 34篇 |
1997年 | 19篇 |
1996年 | 22篇 |
1995年 | 20篇 |
1994年 | 15篇 |
1993年 | 7篇 |
1992年 | 14篇 |
1991年 | 11篇 |
1990年 | 17篇 |
1989年 | 17篇 |
1988年 | 9篇 |
1987年 | 8篇 |
1986年 | 6篇 |
1985年 | 14篇 |
1984年 | 8篇 |
1983年 | 11篇 |
1982年 | 5篇 |
1980年 | 2篇 |
1979年 | 4篇 |
1978年 | 5篇 |
1977年 | 2篇 |
1976年 | 2篇 |
1975年 | 3篇 |
1974年 | 4篇 |
1973年 | 7篇 |
排序方式: 共有1684条查询结果,搜索用时 15 毫秒
31.
32.
33.
Cindy L. Cain Antonella Surbone Ronit Elk Marjorie Kagawa-Singer 《Journal of pain and symptom management》2018,55(5):1408-1419
Palliative care is gaining acceptance across the world. However, even when palliative care resources exist, both the delivery and distribution of services too often are neither equitably nor acceptably provided to diverse population groups. The goal of this study was to illustrate tensions in the delivery of palliative care for diverse patient populations to help clinicians to improve care for all. We begin by defining and differentiating culture, race, and ethnicity, so that these terms—often used interchangeably—are not conflated and are more effectively used in caring for diverse populations. We then present examples from an integrative literature review of recent research on culture and palliative care to illustrate both how and why varied responses to pain and suffering occur in different patterns, focusing on four areas of palliative care: the formation of care preferences, communication patterns, different meanings of suffering, and decision-making processes about care. For each area, we provide international and multiethnic examples of variations that emphasize the need for personalization of care and the avoidance of stereotyping beliefs and practices without considering individual circumstances and life histories. We conclude with recommendations for improving palliative care research and practice with cultural perspectives, emphasizing the need to work in partnerships with patients, their family members, and communities to identify and negotiate culturally meaningful care, promote quality of life, and ensure the highest quality palliative care for all, both domestically and internationally. 相似文献
34.
35.
Jonathan G. Amatruda MD Ronit Katz DPhil Carmen A. Peralta MD MAS Michelle M. Estrella MD MHS Harini Sarathy MBBS MHS Linda F. Fried MD MPH Anne B. Newman MD MPH Chirag R. Parikh MBBS PhD Joachim H. Ix MD MAS Mark J. Sarnak MD MS Michael G. Shlipak MD MPH for the Health ABC Study 《Journal of the American Geriatrics Society》2021,69(3):726-734
36.
Introduction: Diabetes during pregnancy causes both fetal and maternal complications. Insulin is the most effective pharmacological treatment for controlling hyperglycemia during gestation and can limit adverse outcomes. Insulin detemir (IDet), a novel basal insulin, has already been used for this indication for several years. It was reclassified in 2012 by the FDA from category C to category B for the treatment of pregnant women with diabetes.Areas covered: This article reviews published data regarding the use of IDet during pregnancy. We discuss pharmacokinetic and pharmacodynamic qualities of IDet and potential advantages for its use during pregnancy.Expert opinion: IDet is a viable option for the management of diabetes during pregnancy. Though data is limited, its safety and efficacy is probably comparable to human insulin, and in some aspects superior to it. More data, specifically for IDet in pregnancies complicated by gestational diabetes (GDM) or type 2 diabetes, is needed. 相似文献
37.
Koren-Michowitz M Dishy V Zaidenstein R Yona O Berman S Weissgarten J Golik A 《American journal of hypertension》2005,18(3):358-363
BACKGROUND: Thiazide diuretics and angiotensin-converting enzyme inhibitors can cause excessive urinary zinc (Zn) loss and Zn depletion. Thiazides may also induce magnesium (Mg) deficiency, which may exacerbate hypertension. Data on the effects of angiotensin receptor blockers on Zn and Mg homeostasis are scarce. METHODS: Seventeen hypertensive patients were studied (ten men and seven women, age 50 +/- 3 years, blood pressure 158 +/- 5 / 95 +/- 3 mm Hg). Patients were treated with losartan 50 mg/day for 4 weeks followed by a fixed combination of 50 mg losartan and 12.5 mg hydrochlorothiazide for 4 weeks more. Blood and 24-h urine were collected at baseline and after each study period. Zinc and Mg levels were measured in serum, urine, and peripheral blood mononuclear cells. Nitric oxide metabolites were measured in urine. RESULTS: Treatment with losartan resulted in a significant increase in the urinary Zn/creatinine ratio (from 0.020 +/- 0.004 microg/mg to 0.034 +/- 0.005 microg/mg, P = .02), which was further increased by the losartan/hydrochlorothiazide combination (from 0.034 +/- 0.005 microg/mg to 0.053 +/- 0.008 microg/mg, P = .03). Serum Zn levels were significantly decreased after losartan/hydrochlorothiazide (from 80.0 +/- 4.0 microg/dL at baseline to 74.0 +/- 3.0 microg/dL, P = .007). Peripheral blood mononuclear Zn concentrations were decreased also, but this was not statistically significant. Serum, urinary, and peripheral blood mononuclear Mg levels were not significantly affected by treatment. Nitric oxide urinary metabolites were unchanged throughout the study. CONCLUSIONS: Treatment with losartan causes an increase in urinary Zn excretion and induces Zn deficiency in patients with hypertension. The addition of hydrochlorothiazide has an additive effect. Magnesium and nitric oxide metabolism are not affected by either treatment. 相似文献
38.
Validating and implementing the use of an infusion pump for the administration of thawed hematopoietic progenitor cells—a single‐institution experience
下载免费PDF全文
![点击此处可从《Transfusion》网站下载免费的PDF全文](/ch/ext_images/free.gif)
39.
Rimon E Levy S Sapir A Gelzer G Peled R Ergas D Sthoeger ZM 《Archives of internal medicine》2002,162(4):445-449
BACKGROUND: The diagnosis of iron deficiency anemia (IDA) in the elderly is difficult because of the prevalence of chronic diseases, which can cause anemia with high ferritin levels, even in the presence of iron deficiency. Therefore, we studied the sensitivity and specificity of a serum transferrin receptor assay, which is not affected by chronic diseases, in the diagnosis of IDA in elderly patients. METHODS: We performed a prospective controlled study of 49 consecutive male and female patients older than 80 years who were admitted to an acute geriatric department. Bone marrow aspirate confirmed IDA in all 49 patients. Fourteen additional patients, also older than 80 years, with anemia but without evidence of iron deficiency on results of bone marrow examination, served as a control group. All patients underwent evaluation by means of a detailed medical history and results of complete physical examination, routine blood tests, and specific tests for diagnosis and evaluation of anemia. Examination of bone marrow aspirate was performed for all patients. Levels of transferrin receptor in serum were determined by means of a specific enzyme-linked immunosorbent assay. The transferrin receptor-ferritin index (TR-F index) was defined as the ratio of serum transferrin receptor level to log ferritin level. RESULTS: Only 8 patients could be diagnosed as having IDA by means of routine blood test results (serum iron, ferritin, and transferrin saturation levels). In contrast, the TR-F index disclosed IDA in 43 of the 49 patients, thus increasing the sensitivity from 16% to 88%. CONCLUSIONS: The diagnosis of IDA in the elderly by means of routine blood tests has a very low sensitivity. The TR-F index is much more sensitive, and when results are positive, the TR-F index can eliminate the need for bone marrow examination. 相似文献
40.
Rennert G Almog R Tomsho LP Low M Pinchev M Chaiter Y Bonner JD Rennert HS Greenson JK Gruber SB 《Diseases of the colon and rectum》2005,48(12):2317-2321
PURPOSE The probability of colorectal cancer is moderately increased among carriers of the APC I1307K polymorphism. However, it is not known if endoscopic surveillance of this high-risk group is warranted. The prevalence
of polyps and adenomas in specimens of colorectal cancer who are carriers and noncarriers of the APC I1307K polymorphism is compared.
METHOD Prevalence of adenomatous polyps in the pathology specimens of the study participants, stratified by their APC I1307K polymorphism status, was studied in 900 consecutive cases of colorectal cancer diagnosed in northern Israel between
1998 and 2002, within the framework of a population-based, case-controlled study (MECC Study).
RESULTS The APC I1307K mutation was detected in 78 colorectal cancer cases (8.7 percent) of the study population. Prevalence was higher among
Ashkenazi Jews (11.2 percent) than among non-Ashkenazi Jews (2.7 percent) or Arabs (3.1 percent). After adjustment for age,
APC I1307K carriers were significantly more likely than noncarriers to have polyps in their surgical specimen (51.3 percent vs. 32.6 percent, P = 0.002). Adenomas with a tubular component (either tubular adenomas or tubulovillous adenomas), but not villous adenomas,
were significantly more frequent among carriers (37.2 percent vs. 23.6 percent, P = 0.005).
CONCLUSION Together with former evidence of I1307K being a risk factor for colorectal cancer, these data suggest that colonoscopic surveillance
for colorectal adenomas and cancer may be warranted in I1307K carriers, even in the absence of other identifiable risk factors.
Supported by the National Institutes of Health grant RO1-CA81488 to S.B.G. and G.R. 相似文献